2026-01-27 - Analysis Report
# Company Overview
Lam Research is a global manufacturer of semiconductor equipment for the fabrication of integrated circuits, or microchips.

**Return Rate Comparison**
* Cumulative return of review stock (LRCX) = 885.30%
* Cumulative return of comparison stock (S&P 500, VOO) = 127.58%
* Divergence = 737.10; Relative divergence = 94.00%

The cumulative return of LRCX is significantly higher than that of the S&P 500. The divergence suggests that the stock has had a high return rate compared to the comparison stock.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 14.0% | 33.7% | 5.0% | 1.6 | 17.2B |
| 2017-2019  | 89.0% | 33.7% | 64.0% | 1.7 | 36.9B |
| 2018-2020  | 147.0% | 44.4% | 123.0% | 1.5 | 59.5B |
| 2019-2021  | 293.0% | 44.4% | 229.0% | 1.6 | 90.7B |
| 2020-2022  | 2.0% | 54.3% | -3.0% | 1.6 | 53.0B |
| 2021-2023  | 65.0% | 54.3% | 47.0% | 1.8 | 98.8B |
| 2022-2024  | -11.0% | 45.7% | -41.0% | 1.9 | 91.1B |
| 2023-2025  | 482.0% | 46.1% | 406.0% | 2.0 | 215.9B |

The alpha values suggest that the stock has performed well compared to the market average, while the beta values indicate a moderate level of volatility.

**Recent Stock Price Fluctuations**
* Close = $222.87
* 5-day SMA = $222.46
* 20-day SMA = $205.22
* 60-day SMA = $174.54
* Last-market: $222.87 (change: $4.93)

The stock price has shown a moderate increase over the past 5 days, with the 5-day SMA and 20-day SMA being close to the current price. The 60-day SMA is lower than the current price, indicating a potential upward trend.

**RSI, PPO Analysis**
* Market Risk Indicator (MRI) = 0.70 (High Investment Recommended)
* RSI = 66.47
* PPO = -0.24
* Expected Return (%) = 52.00%

The RSI and PPO indicators suggest a moderate level of risk and a potential for increased returns. The MRI indicates a high investment risk.

**Recent News & Significant Events**
* [2026-01-26] Lam Research stock jumps near 3% as Evercore lifts target
* [2026-01-26] Lam Research Sits At Heart Of AI Chip And CHIPS Act Cycle
* [2026-01-02] LRCX Outperformed in 2025, but Valuation and Options Activity Flag 2026 Risks
* [2026-01-26] Lam Research (NASDAQ:LRCX) Trading 2.3% Higher Following Analyst Upgrade
* [2026-01-23] LRCX Likely to Beat Q2 Earnings Estimates: Should You Buy the Stock?
* [2026-01-26] AI-Driven Foundry Demand Likely to Boost LRCX's Systems Revenues in Q2

The recent news and significant events suggest a positive outlook for the company, with upgrades and positive earnings estimates.

**Analyst Opinions**
* Analyst Consensus:
 * Key: Buy
 * Mean (1=StrongBuy~5=Sell): 1.72 (~Buy)
 * Opinions: 31
 * Target Price (avg/high/low): 215.35 / 265.00 / 115.00

The analyst consensus suggests a buy recommendation with a target price range.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-24 | 1.24 | 5.32B |
| 2025-04-25 | 1.04 | 4.72B |
| 2025-01-31 | 0.93 | 4.38B |
| 2024-10-28 | 0.86 | 4.17B |
| 2025-10-24 | 0.86 | 4.17B |

The recent earnings analysis suggests a steady increase in revenue and profitability.

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | 5.32B | 50.43% |
| 2025-06-30 | 5.17B | 50.08% |
| 2025-03-31 | 4.72B | 49.02% |
| 2024-12-31 | 4.38B | 47.37% |
| 2024-09-30 | 4.17B | 48.05% |

The revenue and profit margin have increased over the past quarters.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | 10.19B | 15.39% |
| 2025-06-30 | 9.86B | 17.44% |
| 2025-03-31 | 9.51B | 13.99% |
| 2024-12-31 | 8.81B | 13.52% |
| 2024-09-30 | 8.47B | 13.18% |

The equity and ROE have increased over the past quarters.

**Summary**
The stock has shown a high return rate compared to the comparison stock, with a significant increase in revenue and profitability. The analyst consensus suggests a buy recommendation, and the recent news and significant events suggest a positive outlook for the company. The indicators suggest a moderate level of risk and a potential for increased returns.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.